2018年5月18日星期五

AB423|AB-423||Hepatitis B Virus Capsid Assembly inhibitor

AB423|AB-423||Hepatitis B Virus Capsid Assembly inhibitor

DC Chemicals, Website:www.dcchemicals.com

Product Name: AB423|CAS: 1572510-80-5|Cat No: DC10797|Other Names: AB423,AB-423,AB 423

AB-423 is the first-generation Hepatitis B Virus Capsid Assembly inhibitor, which was generally safe and well tolerated in Phase 1 healthy volunteer studies.

AB-423 is a potent, highly seletive inhibitor of HBV replication through a block of pgRNA encapsidation. AB-423 in combination with EVT has shown synergistic antiviral activity in vitro in primary human hepatocytes. Furthermore, AB-423 alone and in combination with entecavir has shown potent in vivo activity in a hydrodynamic injection (HDI) mouse model of HBV.The HBV capsid inhibitor AB-423 exhibits a dual mode of inhibition:inhibited encapsidation of pgRNA during ongoing infection; inhibited cccDNA synthesis presumably via inhibition of the capsid uncoating step.In vitro AB-423 showed: pan-genotypic activity; potent activity against HBV in combination with Nucs, IFN, and RNAi agents;no significant activity against unrelated viruses.

没有评论:

发表评论